| Product Name | BMS-846372 |
| Product Code | DA-C010-04 |
| Chemical name | 4-(2,3-Dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-1-yl)-1-piperidinecarboxylic acid (6r,9r)-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridin-9-yl ester |
| Synonyms | (6R,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate; |
| Impurity | NA |
| CAS Number | 1190363-03-1 |
| Alternate CAS # | NA |
| Molecular form | C28H27F2N5O3 |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 519.55 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals |
| Boiling Point | NA |
| Applications | BMS-846372 is a potent and orally active human calcitonin gene-related peptide (CGRP) receptor antagonist used for the treatment of migraine. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
